Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Adlercreutzia equolifaciens subsp. celatus

ABSTRACT: Asaccharobacter celatus overview

PROVIDER: PRJNA484815 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	QVPV01.dat.gz	Other
	QVPV01.fasta.gz	Fasta.gz
	QVPV01.master.dat	Other
	SRR3502983.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

Adlercreutzia equolifaciens subsp. celatus DSM 18785

Project description:Adlercreutzia equolifaciens subsp. celatus DSM 18785 Genome sequencing and assembly

| PRJNA234914 | ENA

Complete Genome Sequence of Adlercreutzia equolifaciens subsp. <i>celatus</i> DSM 18785.

Project description:Adlercreutzia equolifaciens subsp. celatus DSM 18785 was isolated from the cecal contents of a rat and is an obligately anaerobic equol-producing bacterium. Here, we report the finished and annotated genome sequence of this organism, which has a genome size of 2,929,991 bp and a G+C content of 63.2%.

| S-EPMC8142583 | biostudies-literature

Adlercreutzia equolifaciens subsp. celatus strain:DSM 18785T

Project description:Adlercreutzia equolifaciens subsp. celatus strain:DSM 18785T Genome sequencing and assembly

| PRJNA698616 | ENA

Adlercreutzia equolifaciens subsp. celatus strain:JCM 14811

Project description:Adlercreutzia equolifaciens subsp. celatus strain:JCM 14811 Genome sequencing and assembly

| PRJNA484653 | ENA

Adlercreutzia equolifaciens

Project description:Adlercreutzia equolifaciens overview

| PRJNA219212 | ENA

Heterologous expression of equol biosynthesis genes from Adlercreutzia equolifaciens.

Project description:Equol is the isoflavone-derived metabolite with the greatest estrogenic and antioxidant activity. It is produced from daidzein by fastidious and oxygen-susceptible intestinal bacteria, which hinders their use at an industrial scale. Therefore, expressing the equol production machinery into easily-cultivable hosts would expedite the heterologous production of this compound. In this work, four genes (racemase, tdr, ddr and dzr) coding for key enzymes involved in equol production in Adlercreutzia equolifaciens DSM19450T were synthesized and cloned in a pUC-derived vector (pUC57-equol) that was introduced in Escherichia coli. Recombinant clones of E. coli produced equol in cultures supplemented with daidzein (equol precursor) and dihydrodaidzein (intermediate compound). To check whether equol genes were expressed in Gram-positive bacteria, the pUC57-equol construct was cloned into the low-copy-number vector pIL252, and the new construct (pIL252-pUC57-equol) introduced into model strains of Lacticaseibacillus casei and Lactococcus lactis. L. casei clones carrying pIL252-pUC57-equol produced a small amount of equol from dihydrodaidzein but not from daidzein, while L. lactis recombinant clones produced no equol from either of the substrates. This is the first time that A. equolifaciens equol genes have been cloned and expressed in heterologous hosts. E. coli clones harboring pUC57-equol could be used for biotechnological production of equol.

| S-EPMC8266531 | biostudies-literature

Transcriptional Regulation of the Equol Biosynthesis Gene Cluster in Adlercreutzia equolifaciens DSM19450T.

Project description:Given the emerging evidence of equol's benefit to human health, understanding its synthesis and regulation in equol-producing bacteria is of paramount importance. Adlercreutziaequolifaciens DSM19450T is a human intestinal bacterium -for which the whole genome sequence is publicly available- that produces equol from the daidzein isoflavone. In the present work, daidzein (between 50 to 200 μM) was completely metabolized by cultures of A.equolifaciens DSM19450T after 10 h of incubation. However, only about one third of the added isoflavone was transformed into dihydrodaidzein and then into equol. Transcriptional analysis of the ORFs and intergenic regions of the bacterium's equol gene cluster was therefore undertaken using RT-PCR and RT-qPCR techniques with the aim of identifying the genetic elements of equol biosynthesis and its regulation mechanisms. Compared to controls cultured without daidzein, the expression of all 13 contiguous genes in the equol cluster was enhanced in the presence of the isoflavone. Depending on the gene and the amount of daidzein in the medium, overexpression varied from 0.5- to about 4-log10 units. Four expression patterns of transcription were identified involving genes within the cluster. The genes dzr, ddr and tdr, which code for daidzein reductase, dihydrodaidzein reductase and tetrahydrodaidzein reductase respectively, and which have been shown involved in equol biosynthesis, were among the most strongly expressed genes in the cluster. These expression patterns correlated with the location of four putative ρ-independent terminator sequences in the cluster. All the intergenic regions were amplified by RT-PCR, indicating the operon to be transcribed as a single RNA molecule. These findings provide new knowledge on the metabolic transformation of daidzein into equol by A.equolifaciens DSM19450T, which might help in efforts to increase the endogenous formation of this compound and/or its biotechnological production.

| S-EPMC6566806 | biostudies-literature

Complete Genome Sequence of the Equol-Producing Bacterium Adlercreutzia equolifaciens DSM 19450T.

Project description:Adlercreutzia equolifaciens DSM 19450(T) was isolated from human feces and is able to metabolize daidzeins (soybean isoflavonoids) to equol. Here, we report the finished and annotated genome sequence of this organism.

| S-EPMC3778203 | biostudies-literature

Adlercreutzia equolifaciens UC1_BHI_P

Project description:Human Microbiome Project (HMP) reference genome

| PRJNA212687 | ENA

Adlercreutzia equolifaciens strain:9CBH6

Project description:Draft genome sequencing of Adlercreutzia equolifaciens strain 9CBH6

| PRJDB12011 | ENA